Neogen Chemicals Stock Falls to 52-Week Low of Rs.1081.05 Amidst Continued Downtrend

Dec 04 2025 10:18 AM IST
share
Share Via
Neogen Chemicals has reached a new 52-week low of Rs.1081.05, marking a significant decline in its share price amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the specialty chemicals segment.



Recent Price Movement and Market Context


On 4 December 2025, Neogen Chemicals' share price touched Rs.1081.05, the lowest level recorded in the past year. This new low comes after three consecutive sessions of decline, during which the stock has delivered a cumulative return of -3.99%. The trading range on the day was relatively narrow, confined to Rs.9.35, indicating limited volatility despite the downward momentum.


The stock's performance today lagged behind its sector peers by 0.78%, while broader market sentiment showed resilience. The Sensex, after an initial dip of 119.25 points, rebounded to close 0.24% higher at 85,310.81, approaching its 52-week high of 86,159.02. The benchmark index is currently trading above its 50-day and 200-day moving averages, supported by gains in mega-cap stocks.


In contrast, Neogen Chemicals is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend in the stock’s price action.



Financial Performance and Profitability Indicators


Over the last year, Neogen Chemicals has recorded a total return of -49.35%, significantly underperforming the Sensex, which has shown a positive return of 5.36% over the same period. The stock’s 52-week high was Rs.2414.90, highlighting the extent of the decline.


The company’s financial metrics reveal several areas of concern. The average Return on Equity (ROE) stands at 9.65%, indicating modest profitability relative to shareholders’ funds. Operating profit has expanded at an annual rate of 14.16% over the past five years, a pace that may be considered moderate within the specialty chemicals industry.


Recent quarterly results have shown negative trends, with the Profit After Tax (PAT) for the latest quarter reported at Rs.3.37 crore, reflecting a decline of 68.5% compared to the previous four-quarter average. The Return on Capital Employed (ROCE) for the half-year period is at a low 5.72%, underscoring limited efficiency in generating returns from capital investments.




Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!



  • - Recently turned profitable

  • - Strong business fundamentals

  • - Pre-breakout opportunity


Catch the Breakout Early →




Debt and Valuation Considerations


Neogen Chemicals carries a relatively high debt burden, with a Debt to EBITDA ratio of 4.01 times. This level suggests a constrained capacity to service debt obligations comfortably. Interest expenses have risen notably, with quarterly interest costs reported at Rs.19.48 crore, representing a growth of 53.75% compared to prior periods.


The company’s valuation metrics reflect a premium stance, with an Enterprise Value to Capital Employed ratio of 2.2. Despite this, the stock is trading at a discount relative to the average historical valuations of its peers in the specialty chemicals sector.


Profitability pressures are further evidenced by a 12.7% decline in profits over the past year, aligning with the stock’s subdued performance. The company’s returns have also lagged behind the BSE500 index across multiple time frames, including the last three years, one year, and three months.



Shareholding and Market Position


Institutional investors hold a significant stake in Neogen Chemicals, accounting for 30.38% of the share capital. These investors typically possess greater resources and analytical capabilities to assess company fundamentals, which may influence trading dynamics and valuation assessments.




Holding Neogen Chemicals from Specialty Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!



  • - Peer comparison ready

  • - Superior options identified

  • - Cross market-cap analysis


Switch to Better Options →




Summary of Performance Trends


Neogen Chemicals’ share price trajectory over the past year has been characterised by a marked decline, culminating in the recent 52-week low. The stock’s underperformance relative to the Sensex and its sector peers reflects a combination of subdued profitability, elevated debt levels, and rising interest expenses.


Financial indicators such as ROE and ROCE point to limited returns on equity and capital employed, while the contraction in quarterly profits adds to the challenges faced by the company. Despite trading at a discount to peer valuations, the stock’s premium enterprise value ratio suggests that market participants are factoring in the company’s financial structure and growth prospects.


In the context of a broader market environment where the Sensex is near its 52-week high and supported by strong mega-cap performance, Neogen Chemicals’ share price movement stands out for its relative weakness.



Technical and Market Positioning


The stock’s position below all major moving averages signals a continuation of bearish momentum. The narrow trading range observed recently may indicate a period of consolidation, though the prevailing trend remains downward. The contrast with the Sensex’s bullish technical positioning highlights the divergence between Neogen Chemicals and the broader market.


Investors and market watchers will note the stock’s significant gap between its current price and the 52-week high of Rs.2414.90, underscoring the scale of the correction experienced over the past year.



Conclusion


Neogen Chemicals’ fall to a 52-week low of Rs.1081.05 reflects a complex interplay of financial and market factors. The company’s profitability metrics, debt servicing capacity, and recent earnings trends have contributed to the subdued market valuation. While the broader market environment remains positive, the stock’s performance highlights the challenges faced within the specialty chemicals sector and the specific pressures on this company.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News